Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
REL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
C21orf33 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DROSHA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRFAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PABPC1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TPD52L2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HAUS7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
FHL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MTCP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SUSD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIF3B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMCHD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP1B1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARID5A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATAD2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AKIRIN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NMNAT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on